308 related articles for article (PubMed ID: 14665494)
1. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.
Goss CH; Rubenfeld GD; Park DR; Sherbin VL; Goodman MS; Root RK
Chest; 2003 Dec; 124(6):2148-55. PubMed ID: 14665494
[TBL] [Abstract][Full Text] [Related]
2. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
3. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria.
Angus DC; Marrie TJ; Obrosky DS; Clermont G; Dremsizov TT; Coley C; Fine MJ; Singer DE; Kapoor WN
Am J Respir Crit Care Med; 2002 Sep; 166(5):717-23. PubMed ID: 12204871
[TBL] [Abstract][Full Text] [Related]
4. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.
Cupurdija V; Lazic Z; Petrovic M; Mojsilovic S; Cekerevac I; Rancic N; Jakovljevic M
J Bras Pneumol; 2015; 41(1):48-57. PubMed ID: 25750674
[TBL] [Abstract][Full Text] [Related]
5. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
Personne V; Chevalier J; Buffel du Vaure C; Partouche H; Gilberg S; de Pouvourville G
Vaccine; 2016 Apr; 34(19):2275-80. PubMed ID: 26979138
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.
McLaughlin JM; Johnson MH; Kagan SA; Baer SL
Infection; 2015 Dec; 43(6):671-80. PubMed ID: 25980561
[TBL] [Abstract][Full Text] [Related]
7. Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin.
Signorovitch JE; Sheng Duh M; Sengupta A; Gu A; Grant R; Raut M; Mody SH; Schein J; Fisher AC; Ng D
Curr Med Res Opin; 2010 Feb; 26(2):355-63. PubMed ID: 19995325
[TBL] [Abstract][Full Text] [Related]
8. Hospitalized low-risk community-acquired pneumonia: outcome and potential for cost-savings.
Hoe LK; Keang LT
Respirology; 1999 Sep; 4(3):307-9. PubMed ID: 10489681
[TBL] [Abstract][Full Text] [Related]
9. Clinical judgment versus the Pneumonia Severity Index in making the admission decision.
Seymann G; Barger K; Choo S; Sawhney S; Davis D
J Emerg Med; 2008 Apr; 34(3):261-8. PubMed ID: 18180134
[TBL] [Abstract][Full Text] [Related]
10. The cost of treating community-acquired pneumonia.
Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
Clin Ther; 1998; 20(4):820-37. PubMed ID: 9737840
[TBL] [Abstract][Full Text] [Related]
11. Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores.
Valencia M; Badia JR; Cavalcanti M; Ferrer M; Agustí C; Angrill J; García E; Mensa J; Niederman MS; Torres A
Chest; 2007 Aug; 132(2):515-22. PubMed ID: 17505026
[TBL] [Abstract][Full Text] [Related]
12. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
13. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.
Johnstone J; Eurich DT; Majumdar SR; Jin Y; Marrie TJ
Medicine (Baltimore); 2008 Nov; 87(6):329-334. PubMed ID: 19011504
[TBL] [Abstract][Full Text] [Related]
14. Variation in management of community-acquired pneumonia requiring admission to Alberta, Canada hospitals.
Jin Y; Marrie TJ; Carriere KC; Predy G; Houston C; Ness K; Johnson DH
Epidemiol Infect; 2003 Feb; 130(1):41-51. PubMed ID: 12613744
[TBL] [Abstract][Full Text] [Related]
15. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
[TBL] [Abstract][Full Text] [Related]
16. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.
Zhou QT; He B; Zhu H
Value Health; 2009; 12(1):40-6. PubMed ID: 18637052
[TBL] [Abstract][Full Text] [Related]
17. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
[No Abstract] [Full Text] [Related]
18. The effects of incorporating a pneumonia severity index into the admission protocol for community-acquired pneumonia.
Jo S; Kim K; Jung K; Rhee JE; Cho IS; Lee CC; Singer AJ
J Emerg Med; 2012 Feb; 42(2):133-8. PubMed ID: 20542398
[TBL] [Abstract][Full Text] [Related]
19. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
Orrick JJ; Segal R; Johns TE; Russell W; Wang F; Yin DD
Pharmacoeconomics; 2004; 22(11):751-7. PubMed ID: 15250752
[TBL] [Abstract][Full Text] [Related]
20. Treatment costs of community-acquired pneumonia in an employed population.
Colice GL; Morley MA; Asche C; Birnbaum HG
Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
